Anna Louise French - Net Worth and Insider Trading

Anna Louise French Net Worth

The estimated net worth of Anna Louise French is at least $56,003 dollars as of 2024-11-13. Anna Louise French is the Director of Jasper Therapeutics Inc and owns about 2,375 shares of Jasper Therapeutics Inc (JSPR) stock worth over $56,003. Details can be seen in Anna Louise French's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anna Louise French has not made any transactions after 2023-04-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anna Louise French

To

Anna Louise French Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anna Louise French owns 1 companies in total, including Jasper Therapeutics Inc (JSPR) .

Click here to see the complete history of Anna Louise French’s form 4 insider trades.

Insider Ownership Summary of Anna Louise French

Ticker Comapny Transaction Date Type of Owner
JSPR Jasper Therapeutics Inc 2023-04-14 director

Anna Louise French Latest Holdings Summary

Anna Louise French currently owns a total of 1 stock. Anna Louise French owns 2,375 shares of Jasper Therapeutics Inc (JSPR) as of April 14, 2023, with a value of $56,003.

Latest Holdings of Anna Louise French

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JSPR Jasper Therapeutics Inc 2023-04-14 2,375 23.58 56,003

Holding Weightings of Anna Louise French


Anna Louise French Form 4 Trading Tracker

According to the SEC Form 4 filings, Anna Louise French has made a total of 1 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Jasper Therapeutics Inc is the sale of 700 shares on April 14, 2023, which brought Anna Louise French around $10,360.

Insider Trading History of Anna Louise French

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anna Louise French Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anna Louise French Ownership Network

Ownership Network List of Anna Louise French

No Data

Ownership Network Relation of Anna Louise French

Insider Network Chart

Anna Louise French Owned Company Details

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Anna Louise French is the director of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Anna Louise French made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net sale of 11,700 shares made by Jeetinder Singh Mahal , a net purchase of 50,000 shares made by Thomas G Wiggans , and a net purchase of 350,000 shares made by Velan Capital Master Fund Lp .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 4,397 shares of Jasper Therapeutics Inc (JSPR) were sold and 545,000 shares were bought by its insiders, resulting in a net purchase of 540,604 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jasper Therapeutics Inc Insider Transactions

No Available Data

Anna Louise French Mailing Address

Above is the net worth, insider trading, and ownership report for Anna Louise French. You might contact Anna Louise French via mailing address: C/o Qiming U.s. Healthcare, 11100 Ne 8th St, Suite 200, Bellevue Wa 98004.